February 16, 2023 Leveraging the SCCM Discovery Virus COVID-19 Registry to Evaluate Drug Repurposing Research Dataset The CURE Repurposing Collaboratory (CDRC) partnered with the SCCM Discovery Virus COVID-19 Registry (Virus) to develop and build..
February 15, 2023 Airway Therapeutics Joins C-Path’s International Neonatal Consortium TUCSON, Ariz., February 15, 2023 — Critical Path Institute (C-Path) today announced that Airway Therapeutics, Inc. (“Airway”
February 8, 2023 TRxA 2023 Funding Opportunities C-Path's Translational Therapeutics Accelerator is a global drug discovery support program...
February 6, 2023 SARC Annual Meeting ASCO 2023 Leading into the annual meeting of the American Society of Clinical Oncology (ASCO), SARC will host the first of two 2023 SARC sem
January 25, 2023 C-Path Receives Letter of Support from EMA on Duchenne Muscular Dystrophy Clinical Trial Simulation Platform TUCSON, Ariz., Jan. 25, 2023 — Critical Path Institute (C-Path) today announced that the European Medicines Agency (EMA) has iss
December 20, 2022 C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for all
December 16, 2022 eCOA Consortium and PRO Consortium Announce Publication of Two Open Access Articles C-Path’s eCOA Consortium and PRO Consortium are pleased to announce the publication of two open access articles in the Jour
December 16, 2022 Qualitative Interview Findings: Comparability of a Provisioned Device Versus Bring Your Own Device…
